All entries for: Bionano Genomics

March 23, 2026

Bionano Genomics

Neutral Outlook

San Diego, CA
201-500 employees

The Inflation Reduction Act of 2022 (“IRA”) also eliminates the coverage gap under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and through a newly established manufacturer discount program.

Disease Area: Oncology, Rare Diseases
Drug Type: Biologic
Scroll to Top